Financial Counselors Inc. increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 2.4% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 240,712 shares of the medical instruments supplier’s stock after purchasing an additional 5,633 shares during the period. Financial Counselors Inc.’s holdings in DENTSPLY SIRONA were worth $6,514,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. Tidal Investments LLC boosted its position in DENTSPLY SIRONA by 292.4% during the first quarter. Tidal Investments LLC now owns 24,149 shares of the medical instruments supplier’s stock valued at $802,000 after acquiring an additional 17,995 shares during the last quarter. Comerica Bank boosted its position in DENTSPLY SIRONA by 2.9% during the first quarter. Comerica Bank now owns 42,568 shares of the medical instruments supplier’s stock valued at $1,413,000 after acquiring an additional 1,205 shares during the last quarter. Virtu Financial LLC bought a new stake in DENTSPLY SIRONA during the first quarter valued at $1,027,000. Cetera Advisors LLC boosted its position in DENTSPLY SIRONA by 18.6% during the first quarter. Cetera Advisors LLC now owns 17,052 shares of the medical instruments supplier’s stock valued at $566,000 after acquiring an additional 2,675 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky boosted its position in DENTSPLY SIRONA by 6.2% during the first quarter. Teachers Retirement System of The State of Kentucky now owns 19,370 shares of the medical instruments supplier’s stock valued at $642,000 after acquiring an additional 1,130 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.
Wall Street Analysts Forecast Growth
XRAY has been the topic of a number of research analyst reports. Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. Needham & Company LLC cut their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Barrington Research cut their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research report on Friday, November 8th. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Finally, Evercore ISI lowered their target price on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Seven investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $29.50.
DENTSPLY SIRONA Stock Up 2.3 %
XRAY opened at $19.64 on Friday. The company has a 50 day moving average of $22.69 and a 200 day moving average of $24.85. The company has a market cap of $3.90 billion, a PE ratio of -9.49, a price-to-earnings-growth ratio of 1.93 and a beta of 1.02. DENTSPLY SIRONA Inc. has a 12 month low of $17.21 and a 12 month high of $37.60. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping the consensus estimate of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. DENTSPLY SIRONA’s revenue for the quarter was up .4% on a year-over-year basis. During the same period last year, the firm earned $0.49 EPS. On average, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Stories
- Five stocks we like better than DENTSPLY SIRONA
- How to Calculate Options Profits
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Best Stocks Under $5.00
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Do S&P 500 Stocks Tell Investors About the Market?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.